How Express Scripts Plans to Disrupt the Emerging Cell and Gene Therapy Channel

How Express Scripts Plans to Disrupt the Emerging Cell and Gene Therapy Channel

Source: 
Drug Channels
snippet: 

Cell and gene therapies are poised to transform the treatment of many serious and previously untreatable conditions.

As this new market develops, payers and PBMs are laying the groundwork for disruptive channel models. Below, I examine how Cigna’s Express Scripts business has begun to shape this channel’s development. Its new models show the promise of private market innovation for the financing and commercialization of novel therapies.